KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Aug 01, 2025 >>  ABB India 5397.45  [ -2.07% ]  ACC 1794.15  [ 0.32% ]  Ambuja Cements 609  [ 2.72% ]  Asian Paints Ltd. 2429.45  [ 1.40% ]  Axis Bank Ltd. 1062.6  [ -0.53% ]  Bajaj Auto 8040.4  [ 0.41% ]  Bank of Baroda 235.1  [ -1.16% ]  Bharti Airtel 1885.1  [ -1.47% ]  Bharat Heavy Ele 231.6  [ -2.81% ]  Bharat Petroleum 317.6  [ -3.49% ]  Britannia Ind. 5803  [ 0.49% ]  Cipla 1501.2  [ -3.41% ]  Coal India 372.4  [ -1.08% ]  Colgate Palm. 2256.3  [ 0.55% ]  Dabur India 533.85  [ 0.90% ]  DLF Ltd. 777.15  [ -0.89% ]  Dr. Reddy's Labs 1219.6  [ -4.03% ]  GAIL (India) 174.3  [ -1.83% ]  Grasim Inds. 2722.3  [ -0.93% ]  HCL Technologies 1452.95  [ -0.98% ]  HDFC Bank 2012.25  [ -0.32% ]  Hero MotoCorp 4312.65  [ 1.18% ]  Hindustan Unilever L 2551.35  [ 1.17% ]  Hindalco Indus. 672.2  [ -1.60% ]  ICICI Bank 1471.4  [ -0.69% ]  Indian Hotels Co 740.85  [ 0.00% ]  IndusInd Bank 783.7  [ -1.90% ]  Infosys L 1470.6  [ -2.52% ]  ITC Ltd. 416.5  [ 1.14% ]  Jindal St & Pwr 945.05  [ -2.07% ]  Kotak Mahindra Bank 1992.1  [ 0.68% ]  L&T 3589.65  [ -1.27% ]  Lupin Ltd. 1865.45  [ -3.28% ]  Mahi. & Mahi 3160.2  [ -1.35% ]  Maruti Suzuki India 12299.35  [ -2.65% ]  MTNL 45.7  [ -0.24% ]  Nestle India 2275.95  [ 1.18% ]  NIIT Ltd. 113.45  [ -2.11% ]  NMDC Ltd. 70.44  [ -0.68% ]  NTPC 330.85  [ -1.02% ]  ONGC 236.85  [ -1.72% ]  Punj. NationlBak 103.15  [ -2.13% ]  Power Grid Corpo 291.2  [ 0.09% ]  Reliance Inds. 1393.6  [ 0.24% ]  SBI 793.95  [ -0.31% ]  Vedanta 424.35  [ -0.22% ]  Shipping Corpn. 210.5  [ -2.50% ]  Sun Pharma. 1629.05  [ -4.49% ]  Tata Chemicals 956.35  [ -2.61% ]  Tata Consumer Produc 1070  [ -0.27% ]  Tata Motors 648.75  [ -2.60% ]  Tata Steel 153  [ -3.04% ]  Tata Power Co. 389.3  [ -2.11% ]  Tata Consultancy 3003.1  [ -1.13% ]  Tech Mahindra 1439  [ -1.71% ]  UltraTech Cement 12105.5  [ -1.08% ]  United Spirits 1322.35  [ -1.34% ]  Wipro 242.8  [ -2.22% ]  Zee Entertainment En 116.35  [ -1.52% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    MANKIND PHARMA LTD.

    01 August 2025 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE634S01028 BSE Code / NSE Code 543904 / MANKIND Book Value (Rs.) 256.00 Face Value 1.00
    Bookclosure 08/08/2025 52Week High 3055 EPS 48.24 P/E 53.20
    Market Cap. 105918.58 Cr. 52Week Low 1901 P/BV / Div Yield (%) 10.02 / 0.00 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    Our Company was incorporated on July 3, 1991 as a private limited company under the Companies Act, 1956, with the name "Mankind Pharma Private Limited", pursuant to a certificate of incorporation granted by the Registrar of Companies, Delhi and Haryana, at New Delhi ("RoC"). Pursuant to the conversion of our Company to a public limited company and as approved by our Shareholders pursuant to a special resolution dated July 14, 2005 the name of our Company was changed to "Mankind Pharma Limited" and the RoC issued a fresh certificate of incorporation on April 13, 2006.

    Major events and milestones:

    2004 
    Entered the chronic pharmaceutical segment with the launch of `Amlokind' tablets and `Glimestar'
    tablets amongst others

    2005 
    -Set up our first manufacturing facility at Paonta Sahib, Himachal Pradesh
    -Entered the ophthalmic pharmaceutical segment with the launch of `Lubistar Eye Drops' and `Tobastar Eye Drops' amongst others

    2007 
    -Entered the consumer healthcare segment with the launch of `Manforce' brand
    -Entered the animal healthcare segment with launch of `Bandykind' and `Ceftiforce' amongst othersRaised ? 720 million from Monet Limited

    2009 
    Set up our manufacturing facility at Unit II, Paonta Sahib, Himachal Pradesh

    2010 
    Launched `Preganews' brand in the consumer healthcare segment

    2012 
    Setup our first R&D centre at IMT Manesar, Haryana

    2014 
    -Acquired Shree Jee Laboratory Private Limited (along with its API manufacturing site situated at Behror, Rajasthan)
    -Set up our manufacturing facility at Unit III, Paonta Sahib, Himachal Pradesh

    2015 
    -Incorporated our Subsidiary, Lifestar Pharma LLC in the US
    -Incorporated our Subsidiary, Mankind Pharma Pte. Limited in Singapore

    2017 
    Set up our manufacturing facility in Sikkim

    2018 
    Our manufacturing facility at Paonta Sahib, Himachal Pradesh was inspected by the USFDA for the first time

    2019 
    Entered the female infertility segment with the launch of `Dydroboon' tablets

    2020 
    -Incorporated our Subsidiary, Lifestar Pharmaceuticals Private Limited in Nepal
    -Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of `Cilaheart' tablets and `Statpure' tablets
    -Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of `Zukanorm' tablets

    2021 
    -Incorporated our Subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE
    -Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of `Mlife' tablets
    -Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of `Trugaba-NT' tablets and `Prebris-MNT' tablets

    2022 
    -Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited
    -Entered into transplant segment with the launch of `Pangraf Capsules' and `Mycept' tablets amongst others
    -Entered into oncology segment with the launch of `Pacliall' injection amongst others
    -Acquired the brands `Daffy' and `Combihale' from Dr. Reddy's Laboratories
    -Our Subsidiary, Mankind Life Sciences Private Limited acquired 90.00% of the issued, subscribed and paid-up share capital of Upakarma Ayurveda Private Limited.

    2023 -Mankind Pharma Sets New Industry Standard with Unprecedented Display on Burj Khalifa, Reinforcing Commitment to Excellence. -Mankind Pharma announced its partnership with SpiceJet to raise awareness about DMF-grade API. -Mankind Pharma Product Prega News and Sonam Kapoor partners to transform from pregnancy detection card to pregnancy care solution.

    2024 -Mankind Pharma Completes Landmark Acquisition of BSV. -Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab. -Mankind Pharma Launches 45-Day Healthcare Mission at Mahakumbh Serving Thousands of Pilgrims with Free Health Check-ups. -Mankind Pharma Prodct Healthok has joined hands with Bikanervala, (Multinational Indian Restaurant and Sweets Chain).

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.